Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HLCS | P50747 | 6/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | ABL1 | P00519 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | PKM | P14618 | 1/20 | 0.69 |
| ▸ | IDE | P14735 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.69 |
| ▸ | CA12 | O43570 | 6/20 | 0.49 |
| ▸ | CA1 | P00915 | 6/20 | 0.49 |
| ▸ | CA2 | P00918 | 6/20 | 0.49 |
| ▸ | CA9 | Q16790 | 6/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6892318 | 1.00 | HLCS (1.00) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL16141170 | 1.00 | HLCS (1.00) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL14600958 | 1.00 | HLCS (1.00) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL12050323 | 1.00 | HLCS (1.00) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL16141168 | 0.98 | HLCS (0.97) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL11719002 | 0.94 | HLCS (0.88) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL29046885 | 0.85 | HLCS (0.73) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL7849030 | 0.85 | HLCS (0.73) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL19249123 | 0.84 | HLCS (1.00) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL22793211 | 0.84 | HLCS (0.73) | HLCSTDP1MEN1ABL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12599673-B2 | Techniques for enhancing the selectivity and efficacy of antimicrobial and anticancer polymer agents | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2026-04-14 | — | — | US | claimed |
| CN-117503645-B | Plant-source anti-allergy soothing oil and preparation method thereof | 瑞孚生物技术(广州)有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-115420832-B | GC-MS fingerprint spectrum and multi-index content determination method for litsea coreana oil | 贵州医科大学 | 2024-03-19 | — | — | CN | claimed |
| US-20240084354-A1 | MEANS AND METHODS FOR REGULATING INTRACELLULAR TRAFFICKING OF SECRETORY OR CELL MEMBRANE-ANCHORED PROTEINS OF INTEREST | HONING BIOSCIENCES (FR) | 2024-03-14 | — | — | US | claimed |
| CN-117503645-A | Plant-source anti-allergy soothing oil and preparation method thereof | 瑞孚生物技术(广州)有限公司 | 2024-02-06 | — | — | CN | claimed |
| EP-4244240-A1 | MEANS AND METHODS FOR REGULATING INTRACELLULAR TRAFFICKING OF SECRETORY OR CELL MEMBRANE-ANCHORED PROTEINS OF INTEREST | Honing Biosciences (FR) | 2023-09-20 | — | — | EP | claimed |
| US-20230055665-A1 | DELIVERY CARRIER INTO CELL | ITO, KABUSIKIKAISYA (JP) | 2023-02-23 | — | — | US | claimed |
| WO-2022101482-A1 | MEANS AND METHODS FOR REGULATING INTRACELLULAR TRAFFICKING OF SECRETORY OR CELL MEMBRANE-ANCHORED PROTEINS OF INTEREST | HONING BIOSCIENCES (FR) | 2022-05-19 | — | — | WO | claimed |
| US-12599673-B2 | Techniques for enhancing the selectivity and efficacy of antimicrobial and anticancer polymer agents | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2026-04-14 | — | — | US | disclosed |
| EP-4709874-A1 | MODULATORS OF PROTEIN SECRETION | Sanofi (FR) | 2026-03-18 | — | — | EP | disclosed |
| US-12578335-B2 | Bioprobes for lysyl oxidases and uses thereof | SYNTARA LIMITED (AU) | 2026-03-17 | — | — | US | disclosed |
| US-20260048140-A1 | NOVEL COPOLYMER | KOWA COMPANY, LTD. (JP) | 2026-02-19 | — | — | US | disclosed |
| EP-4570835-A1 | NOVEL COPOLYMER | KOWA COMPANY, LTD. (JP) | 2025-06-18 | — | — | EP | disclosed |
| CN-120129577-A | Metal powder, method for producing the same, and metal paste | 田中贵金属工业株式会社 | 2025-06-10 | — | — | CN | disclosed |
| WO-2022101482-A1 | MEANS AND METHODS FOR REGULATING INTRACELLULAR TRAFFICKING OF SECRETORY OR CELL MEMBRANE-ANCHORED PROTEINS OF INTEREST | HONING BIOSCIENCES (FR) | 2022-05-19 | — | — | WO | disclosed |
| US-20220142910-A1 | COMPOSITION INCLUDING ALL NATURAL BOTANICAL PEPTIDE INGREDIENTS FOR TOPICAL SKIN APPLICATIONS | MARTIN BASTIAN DIANNE (US) | 2022-05-12 | — | — | US | disclosed |
| US-20210401995-A1 | TECHNIQUES FOR ENHANCING THE SELECTIVITY AND EFFICACY OF ANTIMICROBIAL AND ANTICANCER POLYMER AGENTS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2021-12-30 | — | — | US | disclosed |
| US-20210009569-A1 | SYNTHETIC RECEPTORS FOR IONOPHORIC COMPOUNDS | UNIVERSITEIT GENT (BE) | 2021-01-14 | — | — | US | disclosed |
| EP-1185302-B1 | SPECIFICALLY TARGETED CATALYTIC ANTAGONISTS AND USES THEREOF | GENENCOR INT (US) | 2013-07-24 | — | — | EP | disclosed |
| US-20040170618-A1 | antagonists bind to a recognized target (e.g., a receptor); the enzyme component of the chimera then degrades the target resulting in a reduction of activity of the target and release of the chimeric molecule, which is then free to attack and degrade another target molecule. | DAVIS BENJAMIN G (GB) | 2004-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210401995-A1 | TECHNIQUES FOR ENHANCING THE SELECTIVITY AND EFFICACY OF ANTIMICROBIAL AND ANTICANCER POLYMER AGENTS | BTD, HLCS, CD47 | HLCS 2/4885TDP1 3809/4885MEN1 2632/4885 |
| US-20260048140-A1 | NOVEL COPOLYMER | ERBB3, EGFR, MSR1 | HLCS 2749/4885TDP1 4068/4885MEN1 2388/4885 |
| US-20210009569-A1 | SYNTHETIC RECEPTORS FOR IONOPHORIC COMPOUNDS | TACR1, VIPR1, QRFPR | HLCS 1156/4885TDP1 4640/4885MEN1 3425/4885 |
| US-20230055665-A1 | DELIVERY CARRIER INTO CELL | CTSA, ATG4A, ATG7 | HLCS 1805/4885TDP1 3619/4885MEN1 4742/4885 |
| US-12599673-B2 | Techniques for enhancing the selectivity and efficacy of antimicrobial and anticancer polymer agents | CD47, CFTR, SLC11A2 | HLCS 12/4885TDP1 4838/4885MEN1 4769/4885 |
| US-20240084354-A1 | MEANS AND METHODS FOR REGULATING INTRACELLULAR TRAFFICKING OF SECRETORY OR CELL MEMBRANE-ANCHORED PROTEINS OF INTEREST | PHAX, SCAMP2, YIPF5 | HLCS 1755/4885TDP1 2678/4885MEN1 2782/4885 |
| US-12578335-B2 | Bioprobes for lysyl oxidases and uses thereof | LOXL1, LOX, LOXL2 | HLCS 76/4885TDP1 2300/4885MEN1 4879/4885 |
| US-20040170618-A1 | antagonists bind to a recognized target (e.g., a receptor); the enzyme component of the chimera then degrades the target resulting in a reduction of activity of the target and release of the chimeric molecule, which is then free to attack and degrade another target molecule. | ENGASE, GPR84, ADGRF1 | HLCS 2073/4885TDP1 3376/4885MEN1 3333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.